Research and Markets has announced the addition of the "Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016" report to their offering.
This report provides comprehensive information on the therapeutic development for Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) , complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) Overview
- Therapeutics Development
- Pipeline Products for Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Overview
- Pipeline Products for Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Comparative Analysis
- Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Therapeutics under Development by Companies
- Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Therapeutics under Investigation by Universities/Institutes
- Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Products under Development by Companies
- Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Products under Investigation by Universities/Institutes
- Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Companies Involved in Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/gjlfdm/free_fatty_acid
View source version on businesswire.com: http://www.businesswire.com/news/home/20160526006153/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
